<?xml version="1.0" encoding="UTF-8"?>
<p id="para0033">Taken together, these antiviral drugs may be promising treatment options for the treatment of COVID-19. However, there are also a few points worth noting here: (i) the potential interaction of these antiviral drugs with other therapeutic drugs should be considered; (ii) adverse reactions caused by lopinavir/ritonavir, such as diarrhoea, nausea, vomiting and liver damage, should be also considered; (iii) it is not recommended to use three or more antiviral drugs at the same time, and the use of related drugs should be stopped when there are intolerable side effects; and (iv) further evaluation of the efficacy of current antiviral drugs in clinical applications is needed.</p>
